Publicaciones
-
Muñoz-Vendrell A, Campoy S, Caronna E, Alpuente A, Torres-Ferrus M, Nieves Castellanos C, Olivier M, Campdelacreu J, Prat J, Camiña Muñiz J, Molina Martínez FJ, Mínguez-Olaondo A, Ruibal Salgado M, Santos Lasaosa S, Navarro Pérez MP, Morollón N, López Bravo A, Cano Sánchez LM, García-Sánchez SM, García-Ull J, Rubio-Flores L, Gonzalez-Martinez A, Quintas S, Echavarría Íñiguez A, Gil Luque S, Castro-Sánchez MV, Adell Ortega V, García Alhama J, Berrocal N, Belvís R, Díaz-Insa S, Pozo-Rosich P and Huerta-Villanueva M.
Effectiveness and safety of anti-CGRP monoclonal antibodies in patients over 65 years: a real-life multicentre analysis of 162 patients
JOURNAL OF HEADACHE AND PAIN . 24(1): 63-63. Nº de citas: 28
-
Berrocal N, Bioque M and Bernardo M.
Relationship Between Antipsychotic Medications and Cerebrovascular Disease in Patients With Serious Mental Illness.
JOURNAL OF PSYCHIATRIC PRACTICE . 24(2): 72-78. Nº de citas: 1
-
Berrocal N, Bioque M and Bernardo M.
Is cerebrovascular disease a silent condition in patients with chronic schizophrenia-related disorders?
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY . 32(2): 80-86. Nº de citas: 6
-
Berrocal N and Bernardo M.
Schizophrenia and cerebrovascular disease. A description of a series and bibliographic reivew.
ACTAS ESPANOLAS DE PSIQUIATRIA . 42(2): 74-82. Nº de citas: 4